Glenn R. Mattes Tff Pharmaceuticals, Inc. (TFFP) insider trading activity

TFFP Quotes by TradingView

Glenn R. Mattes is President and CEO of TFF Pharmaceuticals, Inc.. Currently has a direct ownership of 36,000 shares of TFFP, which is worth approximately $11,520. The most recent transaction as insider was on May 16, 2022, when has been sold 16,000 shares (Common Stock) at a price of $4.78 per share, resulting in proceeds of $76,480. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36K
0% 3M change
0% 12M change
Total Value Held $11,520

Glenn R. Mattes Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2022
BUY
Open market or private purchase
$76,480 $4.78 p/Share
16,000 Added 30.77%
36,000 Common Stock
Sep 16 2021
BUY
Open market or private purchase
$71,000 $7.1 p/Share
10,000 Added 33.33%
20,000 Common Stock
Mar 15 2021
SELL
Open market or private sale
$852,000 $17.04 p/Share
50,000 Reduced 83.33%
10,000 Common Stock
Mar 15 2021
BUY
Exercise of conversion of derivative security
$125,000 $2.5 p/Share
50,000 Added 45.45%
60,000 Common Stock
Feb 16 2021
SELL
Open market or private sale
$672,800 $16.82 p/Share
40,000 Reduced 80.0%
10,000 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$100,000 $2.5 p/Share
40,000 Added 44.44%
50,000 Common Stock
Jan 15 2021
SELL
Open market or private sale
$700,400 $17.51 p/Share
40,000 Reduced 80.0%
10,000 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
$100,000 $2.5 p/Share
40,000 Added 44.44%
50,000 Common Stock
Dec 23 2020
SELL
Open market or private sale
$459,900 $15.33 p/Share
30,000 Reduced 75.0%
10,000 Common Stock
Dec 23 2020
BUY
Exercise of conversion of derivative security
$75,000 $2.5 p/Share
30,000 Added 42.86%
40,000 Common Stock
Nov 10 2020
SELL
Open market or private sale
$1,631,362 $14.99 p/Share
108,830 Reduced 91.58%
10,000 Common Stock
Nov 10 2020
BUY
Exercise of conversion of derivative security
$272,075 $2.5 p/Share
108,830 Added 47.8%
118,830 Common Stock
GRM

Glenn R. Mattes

President and CEO
Austin, TX

Track Institutional and Insider Activities on TFFP

Follow TFF Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TFFP shares.

Notify only if

Insider Trading

Get notified when an Tff Pharmaceuticals, Inc. insider buys or sells TFFP shares.

Notify only if

News

Receive news related to TFF Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TFFP